NOV Inc. (NOV)
Official siteENERGY • OIL & GAS EQUIPMENT & SERVICES • NYSE
Market Cap: $6.20B
Last updated: Nov 17, 2026 at 4:20 PM ET
NOV Inc. (NOV) Stock Chart
NOV has a latest price of $16.93 on Nov 17, 2026, 22.5% below its 52-week high of $21.84. Its price rose 8.7% over the past 12 months. The month-end price fell 39.9% over the 10 years through Oct 2026, a compound annual decline of 5.0%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $48.62 in Jul 2018 and its lowest $8.40 in Oct 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NOV with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NOV.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 17.8%, and over 6 months it fell 18.2%. The month-end price fell 3.4% over the 3 years through Oct 2026, a compound annual decline of 1.1%.
| Period | Change |
|---|---|
| 1 month | -9.7% |
| 3 months | -17.8% |
| 6 months | -18.2% |
| 12 months | +8.7% |
| 12 months, with dividends | +11.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -3.4% | -1.1% |
| 5 years | +37.6% | +6.6% |
| 10 years | -39.9% | -5.0% |
Price by Year
Its best calendar year was 2022, when the price rose 54.2%, and its weakest was 2020, when it fell 45.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $19.29 | +23.4% |
| 2025 | $15.63 | +7.1% |
| 2024 | $14.60 | -28.0% |
| 2023 | $20.28 | -2.9% |
| 2022 | $20.89 | +54.2% |
| 2021 | $13.55 | -1.3% |
| 2020 | $13.73 | -45.2% |
| 2019 | $25.05 | -2.5% |
| 2018 | $25.70 | -28.7% |
| 2017 | $36.02 | -3.8% |
Trading Range
The price is 11.7% below its 50-day average of $19.18 and 13.2% below its 200-day average of $19.50.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $16.93 | |
| 52-week high | $21.84 | -22.5% |
| 52-week low | $13.98 | +21.1% |
| 50-day average | $19.18 | -11.7% |
| 200-day average | $19.50 | -13.2% |
Price Risk
Over 3 years, its largest fall from a peak was 45.9%.
| Measure | Value |
|---|---|
| 1-year beta | 0.69 |
| Largest fall, 1 year | -21.7% |
| Largest fall, 3 years | -45.9% |
Valuation
NOV traded at 65.1x earnings at the end of 2025, against a 5-year median of 20.0x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NOV
What is NOV's 1-year price change?
NOV's price rose 8.7% over the past 12 months. With dividends included, the 12-month total return was 11.5%.
What is NOV's 5-year price change?
NOV's month-end price rose 37.6% over the 5 years through Oct 2026, a compound annual rate of 6.6%. These figures leave out dividends.
What is NOV's 52-week high and low?
NOV's 52-week high is $21.84 and its 52-week low is $13.98. Its latest price of $16.93 on Nov 17, 2026 is 22.5% below the high.
What is NOV's beta?
NOV's 1-year beta against the S&P 500 is 0.69, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 21.7%.
Is the NOV chart free?
Yes. Advanced Charting for NOV is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NOV pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors